Integration of metabolomics and transcriptomics reveals metformin suppresses thyroid cancer progression via inhibiting glycolysis and restraining DNA replication
Open Access
- 19 October 2023
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 168, 115659
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81602351)
- Natural Science Foundation of Hunan Province (2017JJ3171)
This publication has 41 references indexed in Scilit:
- Therapeutic potential of metformin in papillary thyroid cancer in vitro and in vivoMolecular and Cellular Endocrinology, 2014
- RNA Sequencing Identifies Multiple Fusion Transcripts, Differentially Expressed Genes, and Reduced Expression of Immune Function Genes in BRAF (V600E) Mutant vs BRAF Wild-Type Papillary Thyroid CarcinomaThe Journal of Clinical Endocrinology & Metabolism, 2014
- Glutamine and cancer: cell biology, physiology, and clinical opportunitiesJournal of Clinical Investigation, 2013
- Emerging roles of PKM2 in cell metabolism and cancer progressionTrends in Endocrinology & Metabolism, 2012
- Metformin Inhibits Growth of Thyroid Carcinoma Cells, Suppresses Self-Renewal of Derived Cancer Stem Cells, and Potentiates the Effect of Chemotherapeutic AgentsThe Journal of Clinical Endocrinology & Metabolism, 2012
- Regulation of cancer cell metabolismNature Reviews Cancer, 2011
- Reactive oxygen species in cancerFree Radical Research, 2010
- Regulation of glutathione synthesisMolecular Aspects of Medicine, 2009
- Role of AMP-activated protein kinase in mechanism of metformin actionJournal of Clinical Investigation, 2001
- Identification of DNA replication and cell cycle proteins that interact with PCNANucleic Acids Research, 1997